MENU
+Compare
MDRX
Stock ticker: OTC
AS OF
Jun 27 closing price
Price
$4.60
Change
+$0.10 (+2.22%)
Capitalization
744.06M

MDRX Veradigm Inc. Forecast, Technical & Fundamental Analysis

Veradigm Inc is a healthcare technology company that drives value through its various combinations of platforms, data, expertise, connectivity, and scale... Show more

MDRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for MDRX with price predictions
Jun 27, 2025

MDRX's MACD Histogram just turned positive

The Moving Average Convergence Divergence (MACD) for MDRX turned positive on June 04, 2025. Looking at past instances where MDRX's MACD turned positive, the stock continued to rise in of 42 cases over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on June 05, 2025. You may want to consider a long position or call options on MDRX as a result. In of 79 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

MDRX moved above its 50-day moving average on May 30, 2025 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for MDRX crossed bullishly above the 50-day moving average on May 23, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 12 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 4 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

MDRX broke above its upper Bollinger Band on June 27, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for MDRX entered a downward trend on June 25, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.632) is normal, around the industry mean (31.808). P/E Ratio (7.919) is within average values for comparable stocks, (163.898). Projected Growth (PEG Ratio) (1.949) is also within normal values, averaging (2.732). Dividend Yield (0.000) settles around the average of (0.030) among similar stocks. P/S Ratio (0.487) is also within normal values, averaging (61.976).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. MDRX’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. MDRX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 88, placing this stock worse than average.

View a ticker or compare two or three
MDRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

MDRX is expected to report earnings to rise 27.27% to 7 cents per share on August 08

Veradigm Inc. MDRX Stock Earnings Reports
Q2'25
Est.
$0.07
Q1'25
Missed
by $0.05
Q4'24
Missed
by $0.12
Q3'24
Beat
by $0.08
Q2'24
Est.
$0.17
The last earnings report on May 09 showed earnings per share of 5 cents, missing the estimate of 10 cents. With 156.29K shares outstanding, the current market capitalization sits at 744.06M.
A.I.Advisor
published Dividends

MDRX paid dividends on October 17, 2008

Veradigm Inc. MDRX Stock Dividends
А dividend of $5.23 per share was paid with a record date of October 17, 2008, and an ex-dividend date of October 08, 2008. Read more...
A.I. Advisor
published General Information

General Information

a provider of information technology solutions and services to healthcare organizations

Industry PackagedSoftware

Profile
Fundamentals
Details
Industry
Information Technology Services
Address
222 Merchandise Mart Plaza
Phone
+1 800 334-8534
Employees
8000
Web
https://www.veradigm.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SDGCX88.600.70
+0.80%
DWS Capital Growth C
POVDX31.790.21
+0.66%
Putnam International Equity R5
SMLKX19.820.05
+0.25%
Shelton S&P Smallcap Index K
JMVZX32.490.06
+0.19%
JPMorgan Mid Cap Value R2
OEQIX8.58-0.04
-0.46%
Oaktree Emerging Markets Equity I

MDRX and Stocks

Correlation & Price change

A.I.dvisor tells us that MDRX and MSAI have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that MDRX and MSAI's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MDRX
1D Price
Change %
MDRX100%
+2.22%
MSAI - MDRX
29%
Poorly correlated
-6.66%
SPPL - MDRX
28%
Poorly correlated
+0.64%
TRAK - MDRX
13%
Poorly correlated
+0.86%
GIGM - MDRX
11%
Poorly correlated
-2.03%
ASUR - MDRX
7%
Poorly correlated
-1.00%
More